Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Theophylline impurity 9 is a known impurity identified in Theophylline. This compound serves as an important reference standard in the analysis and quality control of pharmaceutical formulations. Its characterization is crucial for ensuring compliance with regulatory standards and for understanding the pharmacological profile of Theophylline-containing products in therapeutic and research contexts. -
Drug Impurity
Indobufen impurity 4 is a minor impurity derived from Indobufen, a known antiplatelet agent. This compound is relevant for analytical research in pharmacokinetics and quality control, allowing for comprehensive impurity profiling in drug formulations. Its characterization is essential for ensuring the safety and efficacy of therapeutic agents in development. -
Drug Impurity
N-Methyl-3-nitroaniline is a nitroaniline derivative primarily recognized for its role as a drug impurity. This compound is significant in chemical research for assessing purity levels and evaluating potential safety profiles of pharmaceutical formulations. N-Methyl-3-nitroaniline serves as a critical marker in stability studies and quality control processes within the drug development pipeline. -
Drug Impurity
Levetiracetam impurity 1 is a known impurity associated with the anticonvulsant agent Levetiracetam, primarily targeting the modulation of neurotransmitter release. This impurity can serve as a reference standard in analytical chemistry and pharmacokinetics studies, aiding in the evaluation of drug purity and stability. It is particularly useful in the development and quality control of pharmaceutical formulations containing Levetiracetam. -
Drug Impurity
Noradrenalone impurity 1 hydrochloride is a chemical compound characterized as an impurity of Noradrenalone. It serves as a reference standard for quality control in drug formulation and development, enabling researchers to investigate potential impurities in pharmaceutical products. This reagent is essential for ensuring the purity and safety of Noradrenalone in various biological and chemical research applications. -
Drug Impurity
Umeclidinium bromide impurity 8 is a known impurity of Umeclidinium bromide, which acts as a long-acting muscarinic antagonist (LAMA). This compound is primarily utilized for analytical purposes, especially in the characterization and quality control of pharmaceutical formulations containing Umeclidinium bromide. Its presence and quantification are crucial for ensuring compliance with regulatory standards in drug development and manufacturing. -
Drug Impurity
Clozapine impurity 8 is a known impurity of the atypical antipsychotic clozapine, primarily identified for its role in therapeutic formulations. This compound is essential for assessing the quality and safety of clozapine, aiding in the understanding of its metabolic profile and overall pharmacological impact. Researchers can utilize this impurity in drug development and analytical studies to ensure compliance with regulatory standards for pharmaceutical products. -
Drug Impurity
Tofacitinib impurity 6 is a chemical impurity associated with Tofacitinib, a selective Janus kinase (JAK) inhibitor. It is primarily used to support analytical evaluations and quality control in pharmaceutical research involving Tofacitinib. This compound is essential for the identification and quantification of impurities, facilitating the maintenance of drug safety and efficacy standards. -
Drug Impurity
Sildenafil Impurity 1 is a known impurity of the phosphodiesterase type 5 inhibitor, Sildenafil. Characterized for its relevance in pharmacological studies, this compound serves as a critical reference standard for quality control in the synthesis and analysis of Sildenafil. Its identification and quantification are essential in ensuring the purity and safety of pharmaceutical formulations containing Sildenafil. -
Drug Impurity
Paliperidone impurity 15 is a chemical impurity associated with the antipsychotic agent paliperidone. This impurity serves as a key component for studies focused on the characterization and analysis of pharmaceutical formulations. It is essential for quality control and regulatory compliance in the production of paliperidone and may be utilized in analytical research to elucidate the compound's purity profile. -
Drug Impurity
Candesartan impurity 26 is a known impurity of the angiotensin II receptor blocker, Candesartan. Its presence is significant in the analysis of pharmaceutical formulations and quality control processes. This compound is essential for researchers conducting stability studies, impurity profiling, and regulatory compliance in drug development. -
Drug Impurity
Ethinylestradiol impurity 3 is a known impurity associated with the synthesis of Ethinylestradiol, a synthetic estrogen used in various hormonal therapies. This compound can be utilized in quality control and analytical studies to evaluate the purity of Ethinylestradiol formulations. Its presence in pharmaceutical preparations can affect the efficacy and safety profiles of estrogenic treatments, making it relevant in drug development and regulatory assessments. -
Drug Impurity
Apixaban impurity 46 is a characterized impurity associated with the anticoagulant Apixaban. This compound is crucial for the quality control and validation processes in pharmaceutical research, aiding in the assessment of drug purity and stability. Its analysis is essential for ensuring compliance with regulatory standards in drug development and manufacturing, ultimately contributing to safer therapeutic applications. -
Drug Impurity
Ondansetron impurity 6 is a known impurity associated with the antinausea medication Ondansetron. This compound is essential for assessing the purity and quality of pharmaceutical formulations containing Ondansetron. It serves a critical role in research focused on drug development, formulation stability, and regulatory compliance by providing insights into the compound's synthesis and degradation pathways. -
Drug Impurity
Methyl 2-formyl-5-methoxybenzoate is identified as a drug impurity. This compound may participate in various analytical studies aimed at assessing the purity of pharmaceutical formulations. It is useful for researchers investigating the stability and degradation pathways of benzoate derivatives within the context of drug development. -
Drug Impurity
Methyl 5-formylsalicylate is a recognized drug impurity associated with various pharmaceutical compounds. This compound can serve as an important analytical marker for quality control and stability testing throughout drug development processes. Its examination can provide insights into the metabolic pathways and degradation products of certain drug formulations, aiding in the evaluation of safety and efficacy. -
Drug Impurity
Nintedanib impurity 9 is a specific impurity associated with the drug Nintedanib, which serves as a multiple receptor kinase inhibitor targeting VEGFR, PDGFR, and FGFR. This compound is utilized in research to assess the purity and quality of Nintedanib formulations. Its identification is crucial for compliance with regulatory standards in drug development and quality control processes. -
Drug Impurity
Glycopyrronium impurity 4 is a chemical impurity associated with the synthesis of Glycopyrronium, a muscarinic receptor antagonist. This impurity is relevant for quality control and regulatory compliance during the development and manufacture of pharmaceutical formulations. It can be utilized in analytical studies to assess the purity and stability of Glycopyrronium formulations. -
Drug Impurity
Cinakase impurity 11 is a byproduct associated with the synthesis of Cinakase, a medication used for the treatment of certain hematological malignancies. This impurity is essential for analytical validation and quality control in pharmaceutical research. Its characterization aids in ensuring the safety and efficacy of the final therapeutic product, facilitating compliance with regulatory standards in drug development. -
Drug Impurity
Sitagliptin impurity 5 is a structural variant of Sitagliptin, primarily characterized as a drug impurity. It is utilized in pharmaceutical research and development to understand the profiles and effects of Sitagliptin formulations. This impurity plays a crucial role in chromatographic analysis and quality control assessments of Sitagliptin products, ensuring the integrity and safety of therapeutic compounds. -
Drug Impurity
Prednisolone Impurity 9 is a chemical impurity associated with the corticosteroid prednisolone. Characterizing this impurity is essential for ensuring the quality and safety of pharmaceutical formulations. This reagent is utilized in analytical and quality control studies to identify and quantify impurities, contributing to the overall understanding of drug stability and efficacy. -
Drug Impurity
Furosemide Impurity 7 is a chemical impurity associated with the pharmaceutical compound Furosemide. As a drug impurity, it is relevant for studies focusing on pharmaceutical quality control and toxicological assessments. Research applications include the evaluation of drug purity and stability, as well as understanding the implications of impurities in drug formulations. -
Drug Impurity
Ticagrelor impurity 20 is a chemical impurity associated with the antiplatelet agent Ticagrelor. This compound serves as an important reference standard in the evaluation of Ticagrelor quality and purity. It is utilized in pharmaceutical research and development to ensure the integrity of formulations containing Ticagrelor and to study the effects of impurities on drug efficacy and safety. -
Drug Impurity
Peracetyl Empagliflozin is a known drug impurity related to the SGLT2 inhibitor Empagliflozin. This compound may be utilized in the study of pharmaceutical formulations and stability testing, helping to assess the quality and safety of drug products. Its characterization can provide valuable insights into synthesis pathways and potential degradation mechanisms, supporting research in drug development and regulatory compliance. -
Drug Impurity
Avibactam impurity 1 is a chemical impurity associated with Avibactam, a β-lactamase inhibitor. This compound is critical for quality control and characterization in pharmaceutical research and development. Its analysis is essential for ensuring the purity of Avibactam in clinical formulations and contributes to investigations on drug stability and efficacy. -
Drug Impurity
Dapagliflozin impurity 57 is a chemical impurity associated with Dapagliflozin, an SGLT2 inhibitor used in the treatment of type 2 diabetes. This compound serves as a key reference standard for analytical characterization and quality control in pharmaceutical research. Its presence is crucial for ensuring the purity and safety of therapeutic formulations containing Dapagliflozin, making it essential for regulatory compliance and stability testing. -
Drug Impurity
Ropivacaine impurity 1 hydrochloride is a known impurity related to the local anesthetic Ropivacaine. This compound serves as an important reference standard for the assessment of drug quality and purity in pharmaceutical research and development. Its characterization is crucial for regulatory compliance and ensuring the safety and efficacy of Ropivacaine formulations. -
Drug Impurity
Methotrexate impurity 6 is a known impurity associated with the chemotherapeutic agent Methotrexate. This compound is primarily used for analytical purposes in pharmacokinetic studies and quality control processes. It serves as a reference standard for identifying and quantifying impurities in pharmaceutical formulations containing Methotrexate. -
Drug Impurity
Ticagrelor impurity 25 is a synthetic impurity associated with the antiplatelet agent Ticagrelor, acting primarily on the P2Y12 receptor to inhibit platelet aggregation. This compound serves as a crucial reference material in the analysis and quality control of Ticagrelor formulations, ensuring the purity and efficacy of the drug. Its characterization is essential for pharmacokinetic studies and the development of regulatory guidelines in pharmaceutical research. -
Drug Impurity
Trimetazidine impurity 10 is a chemical impurity associated with the cardioprotective agent Trimetazidine. As a research reagent, it can be utilized in the analysis of Trimetazidine's purity and stability, helping to ensure compliance with pharmacological standards. This impurity is significant for studies involving drug formulation and quality control in pharmaceutical research. -
Drug Impurity
Sorafenib impurity 6 is a known impurity of the multikinase inhibitor Sorafenib, targeting various receptor tyrosine kinases involved in tumor angiogenesis and cell proliferation. This compound serves as a useful reference standard in analytical chemistry and pharmacokinetic studies to assess the purity of Sorafenib formulations. Its characterization aids in ensuring the quality and efficacy of pharmaceutical products containing Sorafenib. -
Drug Impurity
Afatinib impurity 3 is a quantified impurity of Afatinib, a selective irreversible inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. This compound is primarily utilized in the evaluation of drug purity and quality control in pharmaceutical research and development. Its characterization is essential for compliance with regulatory standards and for ensuring the safety and efficacy of Afatinib-based therapies. -
Drug Impurity
Apixaban impurity 11 is a known impurity associated with the anticoagulant Apixaban. This compound is essential for the characterization of Apixaban in pharmaceutical formulations and stability studies. Its presence and quantification are important in ensuring the quality and efficacy of the drug during development and production processes. -
Drug Impurity
Ropinirole impurity 12 is a chemical impurity associated with the analgesic and anti-Parkinson agent, Ropinirole. This compound plays a critical role in the assessment of drug purity and stability, as it can potentially affect the pharmacological profile of the parent compound. Additionally, Ropinirole impurity 12 is useful in research focused on formulation development, quality control, and compliance with regulatory standards for pharmaceutical products. -
Drug Impurity
Indobufen Impurity 6 is a structural impurity associated with Indobufen. It serves as a valuable reference standard for analytical and quality control applications in pharmaceutical research. The characterization of this impurity can aid in assessing the purity and stability of Indobufen formulations, contributing to the understanding of its pharmacological properties. -
Drug Impurity
Terbinafine impurity 1 hydrochloride is a known impurity of the antifungal agent terbinafine hydrochloride. This compound is important for analytical studies focused on drug purity, stability, and formulation development. Researchers can use it to validate analytical methods and ensure compliance with regulatory standards in pharmaceutical testing. -
Drug Impurity
Metoprolol impurity 10 is a characterized impurity of the beta-blocker Metoprolol, primarily affecting the drug's purity assessment and quality control. Its analysis is essential in pharmaceutical research to ensure compliance with regulatory standards. This compound serves as a reference for detecting and quantifying impurities in formulation studies and stability assessments of Metoprolol. -
Drug Impurity
Dronedarone impurity 25 hydrochloride is a designated impurity associated with the antiarrhythmic drug Dronedarone. It serves as a crucial reference standard in the analysis and quality control of Dronedarone, facilitating the evaluation of drug purity and stability. This compound is significant for researchers and pharmaceutical developers engaged in the synthesis, development, and regulatory assessment of cardiovascular therapeutics. -
Drug Impurity
Sitagliptin impurity 29 is a known impurity of the DPP-4 inhibitor Sitagliptin. Its identification and characterization are crucial for assessing the purity of Sitagliptin during drug development and quality control processes. This compound is important for researchers investigating the safety, efficacy, and regulatory compliance of Sitagliptin formulations. -
Drug Impurity
Posaconazole impurity 4 is a characterized impurity of the antifungal agent Posaconazole. It serves as a reference standard for analytical studies and quality control processes in pharmaceutical research. The identification and quantification of this impurity are essential for ensuring the purity and efficacy of Posaconazole formulations in clinical settings. -
Drug Impurity
Sofosbuvir impurity 3 is a characterized impurity of the antiviral agent Sofosbuvir, primarily targeting hepatitis C virus replication. This compound serves as a vital reference standard in the analytical evaluation of Sofosbuvir formulations, ensuring the quality and safety of therapeutic applications. Its assessment is crucial for researchers conducting studies on drug metabolism, stability, and impurity profiling in pharmaceutical development. -
Drug Impurity
Brimonidine impurity 7, also known as 6-Quinoxalinamine, is a chemical impurity associated with the synthesis of Brimonidine. This compound serves as an important reference standard in analytical chemistry for the detection and quantification of impurities in pharmaceutical formulations. Its characterization can aid in understanding the stability and quality of Brimonidine-related products. -
Drug Impurity
Sacubitrilat impurity 34 is a known impurity associated with Sacubitrilat, a vasodilator that inhibits neprilysin, thereby increasing levels of natriuretic peptides. This compound is primarily utilized in drug development and quality control assessments to ensure the purity of Sacubitrilat formulations. Its presence in analytical studies aids in understanding the metabolism and safety profiles of the parent drug. -
Drug Impurity
Dapagliflozin impurity 111 is an impurity associated with the antidiabetic agent Dapagliflozin, which targets sodium-glucose cotransporter 2 (SGLT2). This compound serves as a critical analytical reference for the assessment of drug purity and quality control in pharmaceutical formulations. The study of this impurity is important for understanding the stability and safety profiles of SGLT2 inhibitors in drug development. -
Drug Impurity
Vitamin Impurity 3 is a recognized impurity associated with Vitamin compounds. It may arise during synthesis or degradation processes and is primarily investigated for its potential effects on the stability and efficacy of vitamin formulations. This reagent is essential for quality control and regulatory compliance in pharmaceutical research, allowing scientists to assess the purity of vitamin products and their implications for safety and effectiveness. -
Drug Impurity
4-Chloro-2-methoxybenzonitrile is identified as a drug impurity primarily involved in pharmaceutical applications. Its presence may affect the safety and efficacy of drug formulations, making it a critical compound for analytical chemistry studies. Researchers utilize this reagent to investigate the impact of impurities in drug development and quality control processes. -
Drug Impurity
Ilurodoline impurity 10 is a synthetic impurity associated with the drug Ilurodoline. This compound serves as a valuable reference standard for analytical and quality control applications in the pharmaceutical industry. Its characterization is crucial for ensuring the purity and safety of Ilurodoline in drug formulation and development processes. -
Drug Impurity
Tadalafil impurity 16 is a known impurity of Tadalafil, primarily involved in the assessment of pharmaceutical quality and characterization of drug substances. This compound serves as a critical reference standard for the analysis of Tadalafil formulations, ensuring compliance with regulatory guidelines. Its presence can impact the efficacy and safety profiles of Tadalafil, making it essential for analytical and quality control applications in drug development and manufacturing. -
Drug Impurity
Arolol impurity 2 is a characterized drug impurity associated with Arolol. Due to its presence, it is essential for the assessment of pharmaceutical formulations and quality control processes. This compound is used in research to ensure the purity and safety of drug products, ultimately aiding in the development of therapeutically effective formulations. -
Drug Impurity
Rosuvastatin impurity 52 is a known impurity of the cholesterol-lowering agent Rosuvastatin, primarily affecting its purity profile. This compound is crucial for quality control and analytical studies, aiding in the assessment of synthetic processes and regulatory compliance. It is utilized in pharmaceutical research to ensure the integrity of drug formulations and to evaluate the safety and efficacy of Rosuvastatin.
